|

Osilodrostat (Isturisa) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Isturisa, LCI699, Osilodrostat

Pipeline

Phase 4: 1

Top Sponsors

  • Johns Hopkins University1

Indications

  • Mild Autonomous Cortisol Secretion (MACS)1
  • Cancer1

Baltimore, Maryland1 trial

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Johns Hopkins University School of Medicine

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.